SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity [GEX]
RNA-seq (gene expression) · human · 26 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 26 samples: 26 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- SARS-CoV-2 infection elucidates features of pregnancy-specific immunityCell reports · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE239450_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA999323. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 26 sample titles: 26 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7665278 Pregnant, COVID negative, patient OB7-CTRL (GEX)
- GSM7665279 Pregnant, COVID severe, patient 705385-SEV (GEX)
- GSM7665280 Pregnant, COVID asymptomatic, patient 803763-ASX (GEX)
- GSM7665281 Pregnant, COVID asymptomatic, patient 324058-ASX (GEX)
- GSM7665282 Pregnant, COVID negative, patient 644394-CTRL (GEX)
- GSM7665283 Pregnant, COVID severe, patient 915348-SEV (GEX)
- GSM7665284 Pregnant, COVID negative, patient 729106-CTRL (GEX)
- GSM7665285 Pregnant, COVID asymptomatic, patient 105199-ASX (GEX)
- GSM7665286 Pregnant, COVID severe, patient 101607-SEV (GEX)
- GSM7665287 Non-pregnant, COVID asymptomatic, patient 350 (GEX)
- GSM7665288 Non-pregnant, COVID asymptomatic, patient 31 (GEX)
- GSM7665289 Non-pregnant, COVID asymptomatic, patient 94 (GEX)
- GSM7665290 Non-pregnant, COVID asymptomatic, patient 103 (GEX)
- GSM7665291 Non-pregnant, COVID asymptomatic, patient 78 (GEX)
- GSM7665292 Non-pregnant, COVID asymptomatic, patient 47 (GEX)
- GSM7665293 Non-pregnant, COVID severe, patient 382 (GEX)
- GSM7665294 Non-pregnant, COVID severe, patient 325 (GEX)
- GSM7665295 Non-pregnant, COVID severe, patient 321 (GEX)
- GSM7665296 Non-pregnant, COVID severe, patient 50 (GEX)
- GSM7665297 Non-pregnant, COVID severe, patient 182 (GEX)
- GSM7665298 Non-pregnant, COVID severe, patient 77 (GEX)
- GSM7665299 Non-pregnant, COVID severe, patient 100 (GEX)
- GSM7665300 Non-pregnant, COVID severe, patient 191 (GEX)
- GSM7665301 Non-pregnant, COVID severe, patient 1 (GEX)
- GSM7665302 Non-pregnant, COVID severe, patient 213 (GEX)
- GSM7665303 Non-pregnant, COVID severe, patient 223 (GEX)
- GSE239452 SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity 77 samples shares sars-cov-2, pregnancy-specific, elucidates, features, immunity, unique
- GSE276544 MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity 305 samples shares sars-cov-2, immunity
- GSE297915 Profile of innate immunity in the skin of patients with SARS-CoV-2 13 samples shares sars-cov-2, immunity
- GSE290042 Chromatin disruptions in pathophysiologically relevant gene promoters underlie unique SARS-Cov-2 nucleocapsid-mediated gene regulation 48 samples shares sars-cov-2, unique
- GSE224198 Single-cell multi-omics analysis revealing immune features of inactivated SARS-CoV-2 vaccination in systemic lupus erythematosus patients 26 samples shares sars-cov-2, features
- GSE240766 SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection 101 samples shares sars-cov-2
- GSE272756 SARS-CoV-2 infection of human lung ALI cultures reveals basal cells as relevant targets 54 samples shares sars-cov-2
- GSE250377 SARS-CoV-2 infection response in iPSC-derived alveolar epithelial cell type-2 40 samples shares sars-cov-2
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.